Jump to main content
Topic: Policy
-
R&D Costs Do Not Explain Elevated U.S. Drug Prices
Read More
-
The U.S. Government Should Buy Gilead for $156Bn to Save Money on Hep C
Read More
-
Hospital Outpatient versus Doctor Office Cost for Physician Administered Cancer Drugs
Read More
-
Copay Assistance for Expensive Drugs: A Helping Hand That Raises Costs
Read More
-
Part B Payment for Medicare Drugs
Read More
-
Overspending Driven by Oversized Single Dose Vials of Cancer Drugs
Read More
-
The 340B Program: Hospitals Profit by Reaching Affluent Communities
Read More
-
Unpronounceable Drugs, Incomprehensible Prices
Read More
-
Reforming the Payment System for Medical Oncology
Read More
-
Cost Consequences of the 340B Drug Discount Program
Read More